RB
ONC

Rodgers Brothers’s BeOne Medicines Ltd ONC Stock Holding History

Rodgers Brothers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$906K Hold
3,181
– – 0.09% 149
2026
Q1 		$945K Hold
3,181
– – 0.11% 142
2025
Q4 		$966K Hold
3,181
– – 0.12% 133
2025
Q3 		$1.08M Hold
3,181
– – 0.13% 133
2025
Q2 		$770K Hold
3,181
– – 0.1% 153
2025
Q1 		$866K Hold
3,181
– – 0.12% 137
2024
Q4 		$588K Hold
3,181
– – 0.08% 170
2024
Q3 		$714K Sell
3,181
-369
-10% -$66.4K 0.09% 159
2024
Q2 		$506K Hold
3,550
– – 0.07% 180
2024
Q1 		$555K Buy
3,550
+25
+0.7% +$4.03K 0.08% 169
2023
Q4 		$636K Buy
+3,525
New +$638K 0.1% 149

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rodgers Brothers's ONC Position: Q2 2026 in Review

Rodgers Brothers held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 3,181 shares worth $906K. The position accounts for 0.09% of the portfolio, ranked #149.

Rodgers Brothers first reported a position in ONC in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.08M in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Rodgers Brothers held 3,181 shares of BeOne Medicines Ltd worth $906K as of Q2 2026.
  • Rodgers Brothers left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up 0.09% of Rodgers Brothers's portfolio in Q2 2026, its #149 holding.
  • Rodgers Brothers first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 11 quarters since.
  • Rodgers Brothers's BeOne Medicines Ltd position peaked at $1.08M in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Rodgers Brothers's 13F filing for Q2 2026, filed 5 Aug 2026.